Download PDF
Synfacts 2011(7): 0698-0698  
DOI: 10.1055/s-0030-1260480
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart ˙ New York

Asymmetric Synthesis of HPA-12

Contributor(s): Philip Kocienski
A. Ďuriš, T. Wiesenganger, D. Moravčíková, P. Baran, J. Kožíšek, A. Daïch, D. Berkeš*
Slovak University of Technology, Bratislava, Slovakia; Juniata College, Huntingdon, USA; University of Le Havre, France
Further Information

Publication History

Publication Date:
17 June 2011 (online)

    Permissions and Reprints

Significance

HPA-12 is the first specific inhibitor of sphingomyelin biosynthesis in mammalian cells and an important lead for the treatment of dis­eases dependent on ceramide trafficking. The key step in the synthesis of HPA-12 is the 3-component asymmetric Mannich reaction leading to the γ-oxo-α-amino acid D. The high dr of this ­reaction is a consequence of crystallization-­induced diastereoselection.